Skip to main content
Journal cover image

The Pragmatic Removal of Penicillin Allergy Electronic Health Record Labels (PROPEL) Trial: A Randomized Clinical Trial.

Publication ,  Journal Article
Stone, CA; Prigmore, HL; McCoy, AB; Stollings, JL; Dear, ML; Hiser, W; Van Winkle, G; Kripalani, S; Wright, A; Harrell, FE; Rice, TW ...
Published in: J Allergy Clin Immunol Pract
October 2025

BACKGROUND: Inaccurate penicillin allergy labels (PALs) affect antimicrobial stewardship, health outcomes, and costs. More than 95% of PALs can be de-labeled when tested, but this rarely happens. OBJECTIVE: We sought to determine whether education and an electronic health record (EHR) tool kit to identify low-risk PALs would facilitate inpatient penicillin allergy de-labeling by pharmacists. METHODS: Pragmatic Removal of Penicillin Allergy Electronic Health Record Labels was a stepped-wedge, nonblinded, randomized, controlled, pragmatic clinical trial including 12 inpatient medical units. From November 2020 to November 2021, units entered intervention at 1-month stepped intervals in random order. Medically stable, nonpregnant adults with an her-documented PAL who were hospitalized on intervention units for 24 hours were included. The intervention included pharmacist and nursing education, a patient list for systematic identification of PALs, presentation of a risk-assessment tool, and an oral amoxicillin challenge order set. The primary outcome was removal of PAL by hospital discharge. Secondary outcomes included safety and implementation measures, longer-term continued label removal, and antibiotic use. RESULTS: On 12 randomized units, 2,052 patients with a PAL presented during the 1-year trial. More intervention-exposed patients had EHR-documented penicillin allergy removal compared with controls (45 of 1,018 [4.4%] vs 31 of 1,034 [3%], respectively; adjusted odds ratio = 2.05; 95% CI, 1.08-3.91). More intervention-exposed patients received an EHR-documented penicillin allergy risk assessment than did controls (86 of 1,018 [8.4%] vs 27 of 1,034 [2.6%]; adjusted odds ratio = 6.42; 95% CI, 3.08-13.38). Moreover, 27 of 1,018 intervention patients (2.7%) received amoxicillin challenge compared with 21 of 1,034 control patients (2.0%). All amoxicillin challenges were tolerated. CONCLUSION: Education and deployment of an inpatient EHR tool kit increased the rate of inpatient removal of inaccurate penicillin allergies before discharge.

Duke Scholars

Published In

J Allergy Clin Immunol Pract

DOI

EISSN

2213-2201

Publication Date

October 2025

Volume

13

Issue

10

Start / End Page

2747 / 2755

Location

United States

Related Subject Headings

  • Penicillins
  • Middle Aged
  • Male
  • Humans
  • Female
  • Electronic Health Records
  • Drug Labeling
  • Drug Hypersensitivity
  • Antimicrobial Stewardship
  • Anti-Bacterial Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Stone, C. A., Prigmore, H. L., McCoy, A. B., Stollings, J. L., Dear, M. L., Hiser, W., … Vanderbilt Learning Healthcare System Platform Investigators. (2025). The Pragmatic Removal of Penicillin Allergy Electronic Health Record Labels (PROPEL) Trial: A Randomized Clinical Trial. J Allergy Clin Immunol Pract, 13(10), 2747–2755. https://doi.org/10.1016/j.jaip.2025.07.006
Stone, Cosby A., Heather L. Prigmore, Allison B. McCoy, Joanna L. Stollings, Mary Lynn Dear, William Hiser, Grace Van Winkle, et al. “The Pragmatic Removal of Penicillin Allergy Electronic Health Record Labels (PROPEL) Trial: A Randomized Clinical Trial.J Allergy Clin Immunol Pract 13, no. 10 (October 2025): 2747–55. https://doi.org/10.1016/j.jaip.2025.07.006.
Stone CA, Prigmore HL, McCoy AB, Stollings JL, Dear ML, Hiser W, et al. The Pragmatic Removal of Penicillin Allergy Electronic Health Record Labels (PROPEL) Trial: A Randomized Clinical Trial. J Allergy Clin Immunol Pract. 2025 Oct;13(10):2747–55.
Stone, Cosby A., et al. “The Pragmatic Removal of Penicillin Allergy Electronic Health Record Labels (PROPEL) Trial: A Randomized Clinical Trial.J Allergy Clin Immunol Pract, vol. 13, no. 10, Oct. 2025, pp. 2747–55. Pubmed, doi:10.1016/j.jaip.2025.07.006.
Stone CA, Prigmore HL, McCoy AB, Stollings JL, Dear ML, Hiser W, Van Winkle G, Kripalani S, Wright A, Harrell FE, Rice TW, Lindsell CJ, Phillips EJ, Vanderbilt Learning Healthcare System Platform Investigators. The Pragmatic Removal of Penicillin Allergy Electronic Health Record Labels (PROPEL) Trial: A Randomized Clinical Trial. J Allergy Clin Immunol Pract. 2025 Oct;13(10):2747–2755.
Journal cover image

Published In

J Allergy Clin Immunol Pract

DOI

EISSN

2213-2201

Publication Date

October 2025

Volume

13

Issue

10

Start / End Page

2747 / 2755

Location

United States

Related Subject Headings

  • Penicillins
  • Middle Aged
  • Male
  • Humans
  • Female
  • Electronic Health Records
  • Drug Labeling
  • Drug Hypersensitivity
  • Antimicrobial Stewardship
  • Anti-Bacterial Agents